Association of mdr1 Gene Expression with Other Prognostic Factors and Clinical Outcome in Human Breast Cancer

Journal of the Medical Association of Thailand

Volumn 80, Issue SUPPL. 1, 1997, Pages

  Punyammalee, Boonnum ^a   Manoromana, Suphon ^b   Purisa, Wichai ^a   Chariyalertsak, Sunanta ^a   Rerkamnuaychok, Budsaba ^c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b NATIONAL CANCER INSTITUTE   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; RNA;

ARTICLE; BREAST TUMOR; CHI SQUARE DISTRIBUTION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MULTIDRUG RESISTANCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SOUTHERN BLOTTING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, SOUTHERN; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, MULTIPLE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY;

EID: 2442456924     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. O'Biyan RM, Luce JK, Talley RW, et al. Phase II evaluation of adriamycin in human neoplasia. Cancer 1973; 32 : 1-8.
2. Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies. Cancer Res 1970; 30 : 1174-84.
3. Ling V, Thompson LH. Reduced permeability in Chinese hamster ovarian cells as a mechanism of resistance to colchicine. J Cell Physiol 1973; 83 : 103-16.
4. Beck WT, Mueller TJ, Tanzer LR. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 1979; 39 : 2070-6.
5. Akiyama SI, Fojo A, Hanover JA, et al. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol Genet 1985; 11 : 117-26.
6. Roninson IB, Chin JE, Choi KG, et al. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 1986; 83: 4538-42.
7. Shen DW, Cardarelli C, Hwang J, et al. Multiple drug resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, Adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 1986; 261: 7762-70.
8. Fojo AT, Akiyama SI, Gottesman MM, et al. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines. Cancer Res 1985; 45: 3002-7.
9. Chen C, Chin J, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381-9.
10. Fojo AT, Ueda K, Slamon DJ, et al. Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987; 84: 265-9.
11. Schinkel AH, Borst P. Multidrug resistance mediated by P-glycoproteins. Semin Cancer Biol 1991; 2: 213-26.
12. Bell DR, Gerlach JH, Kartner N, et al. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol 1985; 3 : 311-5.
13. Goldstein LJ, Galski H, Fojo AT, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81 : 116-24.
14. Gerlach JH, Bell DR, Karakousis C, et al. P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol 1987; 5: 1452-60.
15. Sugawara I, Kataoka I, Morishita Y, et al. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988; 48: 1926-9.
16. Fojo AT, Shen DW, Mickley LA, et al. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug resistance gene. J Clin Oncol 1987; 5: 1922-7.
17. Sanfilippo O, Ronchi E, de Marco C, et al. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer 1991; 27: 155-8.
18. Keith WN, Stallard S, Brown R. Expression of mdr1 and gst-p in human breast tumours: comparison to in vitro chemosensitivity. Br J Cancer 1990; 61: 712-6.
19. Merkel DE, Fuqua SAW, Tandon AK, et al. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol 1989; 7: 1129-36.
20. Weber JM, Sircar S, Horvath J, et al. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis (guanylhydrazone). Cancer Res 1989; 49: 5779-83.
21. Verelle P, Meissonnier F, Fonck Y, et al. Clinical relevance of immunohistochemical detection of multidrug resistance of P-glycoprotein in breast carcinoma. J Natl Cancer Inst 1991; 83; 111-6.
22. Linn SC, Honkoop AH, Hoekman K, et al. P53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br J Cancer 1996; 74 : 63-8.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol- chloroform extraction. Anal Biochem 1987; 162 : 156-9.
24. Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 7160-4.
25. Sambrook J, Fritsch EF, Maniatis T. Analysis of genomic DNA by Southern hybridization. In : Molecular cloning : a laboratory manual 2nd ed. Cold Spring Habor Laboratory, Cold Spring Harbor, NY. 1989 : 9.31-9.46.
26. Wallner J, Depisch D, Hopfner M, et al. MDR1 gene expression and prognostic factors in primary breast carcinomas. Eur J Cancer 1991; 27: 1352-5.
27. Hennequin E, Delvincourt C, Poumy C, et al. Expression of mdr1 gene in human breast primary tumors and metastases. Breast Cancer Res Treat 1993; 26: 267-74.
28. Schneider J, Rubio MP, Barbazan MJ, et al. P-glycoprotein, Her-2/neu, and mutant p53 expression in human gynecologic tumors. J Natl Cancer Inst 1994; 86: 850-5.
29. Leis HP. Prognostic parameters for breast carcinoma. The breast. In: Bland KI, Copeland EM, eds. WB Saunders, Philadelphia. 1991 : 331-50.
30. Elledge RM, McGuire WL, Osborne CK. Prognostic factors in breast cancer. Semin Oncol 1992; 19 : 244-53.